Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$770M |
| 2 |
Crown Castle
CCI
|
+$678M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$557M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$437M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$1.22B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.04B |
| 3 |
Amazon
AMZN
|
+$661M |
| 4 |
SHPG
Shire pic
SHPG
|
+$478M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$457M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.25% |
| 2 | Consumer Discretionary | 17.77% |
| 3 | Healthcare | 14.23% |
| 4 | Communication Services | 13.04% |
| 5 | Financials | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INVX
476
Innovex International
INVX
$2.11B
| $10.3M | 0.01% |
211,578
-17,246
| -8% | -$890K |
|
477
Alcoa
AA
$13.3B
| $10.3M | 0.01% |
+316,213
| New | +$10.3M |
|
|
SRUNU
478
DELISTED
Silver Run Acquisition Corporation II Units
SRUNU
| $10.1M | 0.01% |
942,952
-76,612
| -8% | -$799K |
|
|
RVNC
479
DELISTED
Revance Therapeutics, Inc.
RVNC
| $9.99M | 0.01% |
+378,400
| New | +$8.44M |
|
480
Eastman Chemical
EMN
$8.35B
| $9.81M | 0.01% |
+116,783
| New | +$9.41M |
|
|
KA
481
DELISTED
Kineta, Inc. Common Stock
KA
| $9.71M | 0.01% |
14,825
+862
| +6% | +$613K |
|
|
IMMU
482
DELISTED
Immunomedics Inc
IMMU
| $9.58M | 0.01% |
+1,084,996
| New | +$7.62M |
|
483
Turning Point Brands
TPB
$1.68B
| $9.48M | 0.01% |
618,058
-145,373
| -19% | -$2.32M |
|
|
NVDQ
484
DELISTED
Novadaq Technologies Inc.
NVDQ
| $9.38M | 0.01% |
800,619
-455,789
| -36% | -$3.6M |
|
485
JELD-WEN Holding
JELD
$220M
| $9.35M | 0.01% |
288,095
-5,637
| -2% | -$183K |
|
486
PUT
iShares Biotechnology ETF
IBB
$10.5B
| $9.23M | 0.01% |
89,307
+79,008
| +767% | +$7.78M |
|
487
iShares Russell 1000 Growth ETF
IWF
$126B
| $8.87M | 0.01% |
297,936
+236,740
| +387% | +$6.95M |
|
|
SEI
488
Solaris Energy Infrastructure
SEI
$3.28B
| $8.82M | 0.01% |
+764,767
| New | +$8.67M |
|
|
ENLK
489
DELISTED
EnLink Midstream Partners, LP
ENLK
| $8.79M | 0.01% |
518,483
-2,225
| -0.4% | -$38.5K |
|
490
WSFS Financial
WSFS
$4B
| $8.73M | 0.01% |
192,578
+1,785
| +0.9% | +$81.6K |
|
|
CWEN.A
491
DELISTED
Clearway Energy Class A
CWEN.A
| $8.64M | 0.01% |
506,335
-20,462
| -4% | -$351K |
|
492
Kosmos Energy
KOS
$1.64B
| $8.6M | 0.01% |
1,342,075
-107,926
| -7% | -$685K |
|
493
Agios Pharmaceuticals
AGIO
$1.99B
| $8.56M | 0.01% |
166,455
-3,344
| -2% | -$171K |
|
|
WFT
494
DELISTED
Weatherford International plc
WFT
| $8.16M | 0.01% |
2,108,824
-110,880
| -5% | -$564K |
|
|
ICD
495
DELISTED
Independence Contract Drilling, Inc.
ICD
| $8.13M | 0.01% |
104,477
-251
| -0.2% | -$21.9K |
|
|
AAMI
496
Acadian Asset Management
AAMI
$3.4B
| $8.06M | 0.01% |
+542,300
| New | +$8.03M |
|
497
Marcus & Millichap
MMI
$1.23B
| $7.81M | 0.01% |
296,327
+4,850
| +2% | +$122K |
|
498
PUT
iShares US Healthcare ETF
IYH
$3.74B
| $7.8M | 0.01% |
234,615
+207,170
| +755% | +$6.62M |
|
499
USA Compression Partners
USAC
$3.9B
| $6.8M | 0.01% |
415,754
-1,850
| -0.4% | -$30.5K |
|
500
Ovid Therapeutics
OVID
$547M
| $6.74M | 0.01% |
+650,074
| New | +$8.49M |
|
Similar funds
Jennison Associates's Q2 2017 Portfolio in Review
As of Q2 2017, Jennison Associates held 698 positions worth $94.3B, up 1.1% from $93.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jennison Associates withdrew a net $3.11B in Q2 2017, closing 61 positions and reducing 332 holdings. Its most notable exit was NXP Semiconductors, an estimated $452M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Newell Brands worth $125M.
- Jennison Associates's largest Q2 2017 buy was Newell Brands: 2,328,211 shares worth $125M.
- Jennison Associates added most to McDonald's in Q2 2017, an estimated $770M increase.
- Jennison Associates's biggest Q2 2017 reduction was Nike, cutting an estimated $1.22B.
- Jennison Associates fully exited NXP Semiconductors in Q2 2017, selling an estimated $452M.
- Jennison Associates's ten largest holdings make up 27% of its $94.3B portfolio in Q2 2017.
- Jennison Associates opened 62 new positions and closed 61 in Q2 2017.
- Jennison Associates's portfolio value rose 1.1% quarter-over-quarter to $94.3B.
Based on Jennison Associates's 13F filing for Q2 2017, filed 4 Aug 2017.